Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University

计划入组 10,000 人 · 首次发布于 2017 年 1 月 5 日

A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma

计划入组 31 人 · 首次发布于 2023 年 7 月 6 日

Assiut University Heart Hospital

计划入组 10 人 · 首次发布于 2019 年 9 月 17 日

Personalized Vaccine(Second Affiliated Hospital of Wenzhou Medical University)

Anti-CD19/CD22 CAR-T cell therapy (The First Affiliated Hospital Of Soochow University)

CT0591CP Cells therapy (The First Affiliated Hospital of Soochow University)

Lanzhou University Second Hospital

China

The First Hospital of Lanzhou University

China

THE SECOND HOSPITAL OF SHANDONG UNIVERSITY

China

HUTCHMED's Sovleplenib Meets Primary Endpoint in Phase III Trial for Warm Autoimmune Hemolytic Anemia

Personalized Medicine Offers Hope for Young Boy Battling Rare Tumor

The Second Act of Thalidomide: From Teratogen to the Foundation of Targeted Protein Degradation